Results 191 to 200 of about 469,352 (221)

Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis—Burkina Faso, 2014–2015

Journal of Infection, 2018
Lesley McGee, Dinanibé Kambire, Cynthia Whitney   +2 more
exaly  

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

Lancet, The, 2006
Bernard Beall, William Schaffner, Mónica Farley   +2 more
exaly  

Conjugate pneumococcal vaccine

Inpharma Weekly, 1998
openaire   +1 more source

The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in Elderly

Clinical Infectious Diseases, 2015
C H van Werkhoven, Marc Bonten, Diederick Grobbee   +2 more
exaly  

Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older

Vaccine, 2013
Robert Frenck, Daniel Scott, William Gruber   +2 more
exaly  

Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal disease

Vaccine, 2015
Jennifer Verani, José Moraes, Carla Magda Allan Santos Domingues   +2 more
exaly  

Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults

Vaccine, 2019
Íngrid Scully, Daniel Scott, William Gruber   +2 more
exaly  

Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study

Lancet, The, 2003
Ger Rijkers, Anne Schilder
exaly  

Pneumococcal conjugate vaccine

Inpharma Weekly, 1999
openaire   +1 more source

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

Vaccine, 2011
Elizabeth Miller, Pauline Waight, Robert C George   +2 more
exaly